
South & Central America Digital Pathology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery,
Description
South & Central America Digital Pathology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnostics, Teleconsultation, and Training & Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics)
The digital pathology market in South & Central America is expected to grow from US$ 64.74 million in 2022 to US$ 124.38 million by 2028. It is estimated to grow at a CAGR of 11.5% from 2022 to 2028.
Rising Use of Digital Pathology for Cancer Diagnosis Drives Digital Pathology Market in South & Central America
The use of digital pathology allows the in-depth diagnosis of tumors. Traditional pathology services can only help understand the location of tumor cells; this makes it difficult to share the cases for a second review. Digital cancer diagnosis typically involves scanning conventional glass slides to get successive images that are digitally united into a single, whole image that replicates the information on the glass slide. The pictures are combined together from associated clinical/hospitals or labs to provide an integrated picture of each unique cancer condition to the pathologists. Companies are launching new digital pathology tools and technologies for cancer detection. For instance, in January 2021, Roche launched the CE-IVD automated digital pathology algorithms that are capable of uPath HER2 Dual ISH image analysis and uPath HER2 (4B5) image analysis for breast cancer diagnosis, which also helps healthcare providers determine the best treatment strategy for each patient. Artificial intelligence (AI) is used in image analysis algorithms to assist pathologists in achieving quick and accurate patient diagnoses. Further, in May 2022, Hartford HealthCare launched a clinical research and innovation platform in collaboration with Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, to help clinicians deliver accurate diagnoses and enhanced care for patients suffering from breast cancer. In March 2022, Paige launched Paige Breast Lymph Node, a new AI software tool that helps pathologists in the detection of breast cancer that has metastasized to lymph nodes, concurrent with pathologists’ interpretive review. It is designed to improve diagnostic accuracy for the most subtle metastatic foci and has over 98% slide level sensitivity for the detection of metastases of any size. In the same month, Verily partnered with Lumea to combine its AI algorithms with Lumea’s comprehensive end-to-end digital pathology platform for developing products to diagnose and prognose prostate cancer, and provide guidance for selecting appropriate therapy for the same with improved efficiency and objectivity. Thus, with technological developments in cancer diagnostics, the use of digital solutions in the diagnosis of this disease is increasing, thereby fueling the digital pathology market growth.
Market Overview
The digital pathology market in South & Central America is bifurcated into Brazil and the rest of South & Central America. The market in Brazil is anticipated to grow with the highest rate during the forecast period owing to the increasing cancer cases in the country. In the last few years, cancer cases have increased in Brazil. Cancer is one of the major causes for mortality in the country. According to the Brazilian National Cancer Institute (INCA), it is estimated that Brazil will have around 600,000 new cases of cancer during 2018–2019. This rising cancer prevalence has translated into a 60% growth. According to Globocan, in 2020, the number of new cancer cases in Brazil was 592,212. Prostate cancer is the most common cancer in the country. There were 97,278 (16.4%) cases of Prostate cancer in Brazil in 2020. Similarly, 88,492 (14.9%) number of new cases of breast cancer, 55,102 (9.3%) cases of colorectum cancer, 40,409 (6.8%) cases of lung cancer, 30,607 (5.2%) cases of thyroid cancer, and 280,324 (47.3) cases of other cancers were recorded in Brazil. The rising incidence of cancer, together with the growing awareness about the benefits of medical imaging for cancer treatment in Brazil. Digital pathology solution is a major diagnostic tool for cancer patients. It enhances cancer diagnosis. Thus, increase in cancer cases will surge the deployment and integration of digital pathology solutions. Also, the rising prevalence of cancer in Brazil is expected to boost the development of novel products during the forecast years. Thus, the increasing cancer cases in Brazil bolster the digital pathology market growth in South & Central America.
South & Central America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Digital Pathology Market Segmentation
The South & Central America digital pathology Market is segmented into product , type , application and end user.
Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment registered the largest market share in 2022. Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held the larger market share in 2022. Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the larger market share in 2022. Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The pharma and biotech companies segment held the largest market share in 2022. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022. Koninklijke Philips N.V.; Nikon Corporation; PerkinElmer, Inc.; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F.Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation; are the leading companies operating in the digital pathology in the region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Digital Pathology Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America Digital Pathology Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The digital pathology market in South & Central America is expected to grow from US$ 64.74 million in 2022 to US$ 124.38 million by 2028. It is estimated to grow at a CAGR of 11.5% from 2022 to 2028.
Rising Use of Digital Pathology for Cancer Diagnosis Drives Digital Pathology Market in South & Central America
The use of digital pathology allows the in-depth diagnosis of tumors. Traditional pathology services can only help understand the location of tumor cells; this makes it difficult to share the cases for a second review. Digital cancer diagnosis typically involves scanning conventional glass slides to get successive images that are digitally united into a single, whole image that replicates the information on the glass slide. The pictures are combined together from associated clinical/hospitals or labs to provide an integrated picture of each unique cancer condition to the pathologists. Companies are launching new digital pathology tools and technologies for cancer detection. For instance, in January 2021, Roche launched the CE-IVD automated digital pathology algorithms that are capable of uPath HER2 Dual ISH image analysis and uPath HER2 (4B5) image analysis for breast cancer diagnosis, which also helps healthcare providers determine the best treatment strategy for each patient. Artificial intelligence (AI) is used in image analysis algorithms to assist pathologists in achieving quick and accurate patient diagnoses. Further, in May 2022, Hartford HealthCare launched a clinical research and innovation platform in collaboration with Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, to help clinicians deliver accurate diagnoses and enhanced care for patients suffering from breast cancer. In March 2022, Paige launched Paige Breast Lymph Node, a new AI software tool that helps pathologists in the detection of breast cancer that has metastasized to lymph nodes, concurrent with pathologists’ interpretive review. It is designed to improve diagnostic accuracy for the most subtle metastatic foci and has over 98% slide level sensitivity for the detection of metastases of any size. In the same month, Verily partnered with Lumea to combine its AI algorithms with Lumea’s comprehensive end-to-end digital pathology platform for developing products to diagnose and prognose prostate cancer, and provide guidance for selecting appropriate therapy for the same with improved efficiency and objectivity. Thus, with technological developments in cancer diagnostics, the use of digital solutions in the diagnosis of this disease is increasing, thereby fueling the digital pathology market growth.
Market Overview
The digital pathology market in South & Central America is bifurcated into Brazil and the rest of South & Central America. The market in Brazil is anticipated to grow with the highest rate during the forecast period owing to the increasing cancer cases in the country. In the last few years, cancer cases have increased in Brazil. Cancer is one of the major causes for mortality in the country. According to the Brazilian National Cancer Institute (INCA), it is estimated that Brazil will have around 600,000 new cases of cancer during 2018–2019. This rising cancer prevalence has translated into a 60% growth. According to Globocan, in 2020, the number of new cancer cases in Brazil was 592,212. Prostate cancer is the most common cancer in the country. There were 97,278 (16.4%) cases of Prostate cancer in Brazil in 2020. Similarly, 88,492 (14.9%) number of new cases of breast cancer, 55,102 (9.3%) cases of colorectum cancer, 40,409 (6.8%) cases of lung cancer, 30,607 (5.2%) cases of thyroid cancer, and 280,324 (47.3) cases of other cancers were recorded in Brazil. The rising incidence of cancer, together with the growing awareness about the benefits of medical imaging for cancer treatment in Brazil. Digital pathology solution is a major diagnostic tool for cancer patients. It enhances cancer diagnosis. Thus, increase in cancer cases will surge the deployment and integration of digital pathology solutions. Also, the rising prevalence of cancer in Brazil is expected to boost the development of novel products during the forecast years. Thus, the increasing cancer cases in Brazil bolster the digital pathology market growth in South & Central America.
South & Central America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Digital Pathology Market Segmentation
The South & Central America digital pathology Market is segmented into product , type , application and end user.
Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment registered the largest market share in 2022. Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held the larger market share in 2022. Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the larger market share in 2022. Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The pharma and biotech companies segment held the largest market share in 2022. Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2022. Koninklijke Philips N.V.; Nikon Corporation; PerkinElmer, Inc.; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F.Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; and Danaher Corporation; are the leading companies operating in the digital pathology in the region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Digital Pathology Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America Digital Pathology Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
151 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 South & Central America Digital Pathology Market – By Product
- 1.3.2 South & Central America Digital Pathology Market – By Type
- 1.3.3 South & Central America Digital Pathology Market – By Application
- 1.3.4 South & Central America Digital Pathology Market – By End User
- 1.3.5 South & Central America Digital Pathology Market – By Country
- 2. Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. South & Central America Digital Pathology Market – Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 South & Central America PEST Analysis
- 4.3 Experts Opinion
- 5. South & Central America Digital Pathology Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Technological Advancements in Digital Pathology Systems
- 5.1.2 Growing Preference for Telepathology in Remote Areas
- 5.1.3 Use of Digital Pathology for Cancer Diagnosis
- 5.2 Market Restraints
- 5.2.1 High Cost of Digital Pathology Systems
- 5.2.2 Shortage of Skilled Professionals to Operate Digital Pathology Systems
- 5.3 Market Opportunities
- 5.3.1 Use of Digital Pathology in Drug Development
- 5.4 Future Trends
- 5.4.1 Use of Artificial Intelligence
- 5.5 Impact Analysis
- 6. Digital Pathology Market – South & Central America Analysis
- 6.1 South & Central America Digital Pathology Market Revenue Forecast and Analysis
- 7. South & Central America Digital Pathology Market Revenue and Forecast to 2028 – by Product
- 7.1 Overview
- 7.2 South & Central America Digital Pathology Market, By Product 2022 & 2028 (%)
- 7.2.1 South and Central America Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 7.2.2 South and Central America Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- 7.3 Scanners
- 7.3.1 Overview
- 7.3.2 South & Central America Scanners Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.3 Integrated
- 7.3.3.1 Overview
- 7.3.3.2 South & Central America Integrated Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.4 Standalone
- 7.3.4.1 Overview
- 7.3.4.2 South & Central America Standalone Market Revenue and Forecast to 2028 (US$ Mn)
- 7.4 Software
- 7.4.1 Overview
- 7.4.2 South & Central America Software Market Revenue and Forecast to 2028 (US$ Mn)
- 7.5 Communication System
- 7.5.1 Overview
- 7.5.2 South & Central America Communication System Market Revenue and Forecast to 2028 (US$ Mn)
- 7.6 Storage
- 7.6.1 Overview
- 7.6.2 South & Central America Storage Market Revenue and Forecast to 2028 (US$ Mn)
- 8. South & Central America Digital Pathology Market Analysis – by Type
- 8.1 Overview
- 8.2 South & Central America Digital Pathology Market Revenue Share, by Type (2022 and 2028)
- 8.2.1.1 South and Central America: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
- 8.3 Human Pathology
- 8.3.1 Overview
- 8.3.2 South & Central America Human Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- 8.4 Veterinary Pathology
- 8.4.1 Overview
- 8.4.2 South & Central America Veterinary Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- 9. South & Central America Digital Pathology Market Analysis – by Application
- 9.1 Overview
- 9.2 South & Central America Digital Pathology Market, By Application 2022 & 2028 (%)
- 9.2.1 South and Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 9.3 Drug Discovery
- 9.3.1 Overview
- 9.3.2 South & Central America Drug Discovery Market Revenue and Forecast to 2028 (US$ Mn)
- 9.4 Disease Diagnostics
- 9.4.1 Overview
- 9.4.2 South & Central America Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
- 9.5 Teleconsultation
- 9.5.1 Overview
- 9.5.2 South & Central America Teleconsultation Market Revenue and Forecast to 2028 (US$ Mn)
- 9.6 Training and Education
- 9.6.1 Overview
- 9.6.2 South & Central America Training and Education Market Revenue and Forecast to 2028 (US$ Mn)
- 10. South & Central America Digital Pathology Market Analysis – by End User
- 10.1 Overview
- 10.2 South & Central America Digital Pathology Market Revenue Share, by End User (2022 and 2028)
- 10.2.1 South and Central America: Digital Pathology Market, by End user – Revenue and Forecast to 2028 (US$ Million)
- 10.3 Pharma and Biotech Companies
- 10.3.1 Overview
- 10.3.2 South & Central America Pharma and Biotech Companies: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.4 Hospital
- 10.4.1 Overview
- 10.4.2 South & Central America Hospital: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.5 Academic
- 10.5.1 Overview
- 10.5.2 South & Central America Academic: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- 11. South & Central America Digital Pathology Market Revenue and Forecast to 2028– by Country
- 11.1 South and Central America Digital Pathology Market
- 11.1.1 Overview
- 11.1.3 South and Central America: Digital Pathology Market, by Country, 2022 & 2028 (%)
- 11.1.3.1 Brazil: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
- 11.1.3.1.1 Overview
- 11.1.3.1.2 Brazil Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- 11.1.3.1.3 Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 11.1.3.1.4 Brazil: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- 11.1.3.1.4.1 Brazil: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
- 11.1.3.1.5 Brazil: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 11.1.3.1.6 Brazil: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
- 11.1.3.2 Argentina: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
- 11.1.3.2.1 Overview
- 11.1.3.2.2 Argentina Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- 11.1.3.2.3 Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 11.1.3.2.4 Argentina: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- 11.1.3.2.4.1 Argentina: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
- 11.1.3.2.5 Argentina: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 11.1.3.2.6 Argentina: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
- 11.1.3.3 Rest of the South and Central America: Digital Pathology Market – Revenue and Forecast to 2028 (USD Million)
- 11.1.3.3.1 Overview
- 11.1.3.3.2 Rest of the South and Central America Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- 11.1.3.3.3 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 11.1.3.3.4 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- 11.1.3.3.5 Rest of South & Central America: Digital Pathology Market, by Type, 2020–2028 (US$ Million)
- 11.1.3.3.6 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts To 2028, By Application (US$ Million)
- 11.1.3.3.7 Rest of South & Central America: Digital Pathology Market Revenue and Forecasts To 2028, By End user (US$ Million)
- 12. South & Central America Digital Pathology Market –Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in the South & Central America Digital Pathology Market (%)
- 12.3 Organic Developments
- 12.3.1 Overview
- 12.4 Inorganic Developments
- 12.4.1 Overview
- 13. Company Profiles
- 13.1 Koninklijke Philips N.V.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Nikon Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 PerkinElmer, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 3DHISTECH Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Hamamatsu Photonics K.K.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 F. Hoffmann-La Roche Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Visiopharm A/S
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Glencoe Software, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Danaher Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms, Digital Pathology Market
- LIST OF TABLES
- Table 1. South and Central America Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 2. South and Central America Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- Table 3. South and Central America: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
- Table 4. South and Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 5. South and Central America: Digital Pathology Market, by End user – Revenue and Forecast to 2028 (US$ Million)
- Table 6. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 7. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- Table 8. Brazil: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
- Table 9. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 10. Brazil: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
- Table 11. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 12. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- Table 13. Argentina: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
- Table 14. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 15. Argentina: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
- Table 16. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Product (US$ Million)
- Table 17. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, by Scanners (US$ Million)
- Table 18. Rest of South & Central America: Digital Pathology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
- Table 19. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By Application (US$ Million)
- Table 20. Rest of South & Central America: Digital Pathology Market Revenue and Forecasts to 2028, By End user (US$ Million)
- Table 21. Organic Developments in the South & Central America Digital Pathology Market
- Table 22. Inorganic Developments in the South & Central America Digital Pathology Market
- Table 23. Glossary of Terms, Digital Pathology Market
- LIST OF FIGURES
- Figure 1. South & Central America Digital Pathology Market Segmentation
- Figure 2. South & Central America Digital Pathology Market, By Country
- Figure 3. South & Central America Digital Pathology Market Overview
- Figure 4. Scanners Segment Held Largest Share of Product Segment in South & Central America Digital Pathology Market
- Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
- Figure 6. South & Central America: PEST Analysis
- Figure 7. Experts Opinion
- Figure 8. Impact Analysis of Drivers and Restraints
- Figure 9. South & Central America Digital Pathology Market – Revenue Forecast and Analysis – 2020- 2028
- Figure 10. South & Central America Digital Pathology Market, by Product 2022 & 2028 (%)
- Figure 11. South & Central America Scanners Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 12. South & Central America Integrated Market Revenue and Forecasts To 2028 (US$ MN)
- Figure 13. South & Central America Standalone Market Revenue and Forecasts To 2028 (US$ MN)
- Figure 14. South & Central America Software Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 15. South & Central America Communication System Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 16. South & Central America Storage Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 17. South & Central America Digital Pathology Market Revenue Share, by Type (2022 and 2028)
- Figure 18. South & Central America Human Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 19. South & Central America Veterinary Pathology: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 20. South & Central America Digital Pathology Market, by Application 2022 & 2028 (%)
- Figure 21. South & Central America Drug Discovery Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 22. South & Central America Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 23. South & Central America Teleconsultation Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 24. South & Central America Training and Education Market Revenue and Forecasts to 2028 (US$ Mn)
- Figure 25. Pathology Market Revenue Share, by End User (2022 and 2028)
- Figure 26. South & Central America Pharma and Biotech Companies: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 27. South & Central America Hospital: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 28. South & Central America Academic: Digital Pathology Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 29. South and Central America Digital Pathology Market Revenue Overview, by Country, 2022 (US$ Million)
- Figure 30. South and Central America: Digital Pathology Market, by Country, 2022 & 2028 (%)
- Figure 31. Brazil: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Argentina: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- Figure 33. Rest of the South and Central America: Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)
- Figure 34. Growth Strategies in the South & Central America Digital Pathology Market (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.